Difference between revisions of "Drug index"
Jump to navigation
Jump to search
(→T) |
(→A) |
||
| Line 8: | Line 8: | ||
*[[Alemtuzumab (Campath)]] | *[[Alemtuzumab (Campath)]] | ||
*[[Altretamine (Hexalen)]] | *[[Altretamine (Hexalen)]] | ||
| + | *[[AMG 386]] '''in clinical trials''' | ||
*[[Aminoglutethimide (Cytadren)]] | *[[Aminoglutethimide (Cytadren)]] | ||
*[[Amsacrine (Amsidine)]] | *[[Amsacrine (Amsidine)]] | ||
Revision as of 15:49, 20 December 2011
- List of chemotherapy regimens
- Vesicant & irritant chemotherapy
- Antiemetic support
- Steroid conversions
- Third party patient information sheets (password protected)
A
- Aldesleukin (Proleukin)
- Alemtuzumab (Campath)
- Altretamine (Hexalen)
- AMG 386 in clinical trials
- Aminoglutethimide (Cytadren)
- Amsacrine (Amsidine)
- Anagrelide (Agrylin)
- Anastrozole (Arimidex)
- Arsenic trioxide (Trisenox)
- Asparaginase (Elspar)
- Atovaquone (Mepron)
- Azacitidine (Vidaza)
B
- Bacillus Calmette-Guerin (BCG, TheraCys)
- Bendamustine (Treanda)
- Bevacizumab (Avastin)
- Bexarotene (Targretin)
- Bicalutamide (Casodex)
- Bleomycin (Blenoxane)
- Bortezomib (Velcade)
- Busulfan (Myleran)
C
- Cabazitaxel (Jevtana)
- Cabozantinib (XL184) in clinical trial
- Capecitabine (Xeloda)
- Carboplatin (Paraplatin)
- Carmustine (BiCNU)
- Cetuximab (Erbitux)
- Chlorambucil (Leukeran)
- Cisplatin (Platinol)
- Cladribine (Leustatin)
- Clofarabine (Clolar)
- Crizotinib (Xalkori)
- Cyclophosphamide (Cytoxan)
- Cytarabine (Cytosar)
- Cytarabine liposomal (DepoCyt)
D
- Dacarbazine (DTIC)
- Dactinomycin (Cosmegen)
- Dasatinib (Sprycel)
- Daunorubicin (Cerubidine)
- Daunorubicin liposomal (DaunoXome)
- Decitabine (Dacogen)
- Degarelix (Firmagon)
- Denileukin diftitox (Ontak)
- Docetaxel (Taxotere)
- Doxorubicin (Adriamycin)
- Doxorubicin liposomal (Doxil)
- Dutasteride (Avodart)
E
- Epirubicin (Ellence)
- Eribulin (Halaven)
- Erlotinib (Tarceva)
- Estramustine (Emcyt)
- Etoposide (Vepesid)
- Everolimus (Afinitor)
- Estramustine (Emcyt)
- Exemestane (Aromasin)
F
- Filgrastim (Neupogen)
- Finasteride (Proscar)
- Fluorouracil (5-FU)
- Floxuridine (FDUR)
- Fludarabine (Fludara)
- Flutamide (Eulexin)
- Folinic acid (Leucovorin)
- Fulvestrant (Faslodex)
G
H
I
- Ibritumomab (Zevalin)
- Idarubicin (Idamycin)
- Ifosfamide (Ifex)
- Imatinib (Gleevec)
- Ipilimumab (Yervoy)
- Interferon alfa-2a (Roferon-A)
- Interferon alfa-2b (Intron-A)
- Irinotecan (Camptosar)
- Ixabepilone (Ixempra)
L
M
- Mechlorethamine (Mustargen)
- Melphalan (Alkeran)
- Mercaptopurine (Purinethol)
- Mesna (Mesnex)
- Methotrexate (MTX)
- Mitomycin (Mutamycin)
- Mitotane (Lysodren)
- Mitoxantrone (Novantrone)
N
O
P
- Paclitaxel (Taxol)
- Paclitaxel, nanoparticle albumin-bound (Abraxane)
- Panitumumab (Vectibix)
- Peg-asparginase (Oncospar)
- Pegfilgrastim (Neulasta)
- Pemetrexed (Alimta)
- Pentamidine (Nebupent)
- Pentostatin (Nipent)
- Pertuzumab (Omnitarg) in clinical trials
- Plicamycin (Mithracin)
- Porfimer (Photofrin)
- Pralatrexate (Folotyn)
- Prednisone (Sterapred)
- Procarbazine (Matulane)
R
- Raloxifene (Evista)
- Rituximab (Rituxan)
- Romidepsin (Isodax)
- Romiplostim (Nplate)
- Ruxolitinib (Jakafi) - FDA approved 11/16/2011
S
- Sargramostim (Leukine/GM-CSF)
- Sipuleucel-T (Provenge)
- Sorafenib (Nexavar)
- Streptozocin (Zanosar)
- Sunitinib (Sutent)
T
- Tamoxifen (Nolvadex)
- Temozolmide (Temodar)
- Temsirolimus (Torisel)
- Teniposide (Vumon)
- Thalidomide (Thalomid)
- Thioguanine (Tabloid)
- Thiotepa (Thioplex)
- Topotecan (Hycamtin)
- Toremifene (Fareston)
- Tositumomab & I-131 (Bexxar)
- Trabectedin (Yondelis)
- Trastuzumab (Herceptin)
- Trastuzumab emtansine (T-DM1) in clinical trials
- Tretinoin (Vesanoid)
- Trimethoprim/Sulfamethoxazole (Bactrim DS)
- Triptorelin (Trelstar LA)
U
V
- Vinblastine (Velban)
- Vincristine (Oncovin)
- Vindesine (Eldisine)
- Vinorelbine (Navelbine)
- Vorinostat (Zolinza)